Skip to main content
European Commission logo print header

Programme Category


Article available in the following languages:


Support for enhancing and demonstrating the impact of KET Biotechnology projects


The coordination action should aim in particular to actively cluster existing activities under the KET Biotechnology programme of Horizon 2020 and might also include related prior activities launched under FP7.

Activities may include:

  • Reviews of recent technological developments, publications, international R&I programmes within the technological area of the cluster;
  • Workshops with top-ranked international experts from various disciplines aiming at the elaboration of future KET Biotechnology priorities within this cluster and identifying research gaps;
  • Science Intelligence: Gathering information about business trends and market prospects within and outside the EU, including relevant analytical and information/publication activities;
  • Promotion of the activities of the cluster, e.g. organizing international conferences, and national or international road shows highlighting the achievements within the cluster, involving also policy makers and/or the general public.

The Commission considers that proposals requesting a contribution from the EU between EUR 700000 and 1000000 would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Dissemination, exploitation and transfer of project results are crucial activities during project life-time and beyond in order to make sure that projects have the expected impacts. Clustering of project activities, according to objectives and addressed themes, and linking them with corresponding existing technology transfer activities are effective ways to stimulate the uptake of project results and the exploitation of synergies. An adequate monitoring of such activities during the project lifetime and beyond is also needed to ensure an effective implementation at programme level.

  • Speeding up industrial exploitation and uptake of results of KET Biotechnology projects.
  • Stimulating network and alliance formation for further RTD and industrial innovation based on KET Biotechnology achievements, including the development and practical application of a clustering model.
  • Added value beyond the original scope of the KET Biotechnology projects by exploiting synergies and sharing best practice. Increased public awareness of the activities in this area by targeted communication activities.
  • More effective execution of activities of common interest, such as IPR management, standardisation and policy making.